SCHLACKMAN SCOTT

Director · MED

As of 2026-09-16, SCHLACKMAN SCOTT has 4 Form 4 transactions on record across 1 company — 3 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $505KIndirect: $0$505Kas of 2026-09-16
  • Direct $505K
  • Indirect $0
MEDdirect42,229 sh$505K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

MED · 4 trades
2026-05-26: Award / grant, 11,680 sh ($0)2026-05-11: Purchase, 2,500 sh ($31K)2026-05-08: Purchase, 2,500 sh ($32K)2025-06-25: Award / grant, 11,168 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-05-11MEDPurchase2,500 @ $12.53$31K+8.9% of holding30,549Form 4
2026-05-08MEDPurchase2,500 @ $12.65$32K+9.8% of holding28,049Form 4
2 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-05-26MEDAward / grant11,68042,229Form 4
2025-06-25MEDAward / grant11,16825,549Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.